CD26/Dipeptidylpeptidase IV-targeted Therapy of Acute Lung Rejection in Rats

Journal of Heart and Lung Transplantation

Volumn 25, Issue 9, 2006, Pages 1109-1116

  Jung, Florian Johannes ^a   Yang, Lin ^a   De Meester, Ingrid ^b   Augustyns, Koen ^b   Cardell, Markus ^a   Hillinger, Sven ^a   Vogt, Peter ^a   Lardinois, Didier ^a   Scharpé, Simon ^b   Weder, Walter ^a   Korom, Stephan ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AB 197; ALLOANTIGEN; BIS(4 ACETAMIDOPHENYL) 1 PROLYLPYRROLIDINE 2 PHOSPHONATE; CYCLINE; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; AIRWAY PRESSURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCOSA; CARBON DIOXIDE TENSION; CELL INFILTRATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; GRAFT RECIPIENT; IMMUNE RESPONSE; LUNG FUNCTION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; MIXED LYMPHOCYTE REACTION; MORPHOMETRICS; NONHUMAN; ORGAN DONOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; STAINING;

ANIMALS; ANTIGENS, CD26; CELL PROLIFERATION; DIPEPTIDES; ENZYME INHIBITORS; GRAFT REJECTION; ISOANTIGENS; LUNG; LUNG TRANSPLANTATION; MALE; RATS; RATS, INBRED STRAINS;

EID: 33748163907     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.05.005     Document Type: Article

References (48)

1. Simeoni L., Rufini A., Moretti T., et al. Human CD26 expression in transgenic mice affects murine T-cell populations and modifies their subset distribution. Hum Immunol 63 (2002) 719-730
2. Morimoto C., and Schlossman S. The structure and function of CD26 in the T-cell immune response. Immunol Rev 161 (1998) 55-70
3. Ikushima H., Munakata Y., Iwata S., et al. Soluble CD26/dipeptidyl peptidase IV enhances transendothelial migration via its interaction with mannose 6-phosphate/insulin-like growth factor II receptor. Cell Immunol 215 (2002) 106-110
4. Kruschinski C., Skripuletz T., Bedoui S., et al. CD26 (dipeptidyl peptidase IV)-dependent recruitment of T cells in a rat asthma model. Clin Exp Immunol 139 (2005) 17-24
5. De Meester I., Korom S., Van Damme J., and Scharpé S. CD26, let it cut or cut it down. Immunol Today 20 (1999) 367-375
6. Tanaka T., Kameoka J., Yaron A., Schlossman S.F., and Morimoto C. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc Natl Acad Sci USA 90 (1993) 4586-4590
7. Tanaka T., Duke-Cohan J., Kameoka J., et al. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc Natl Acad Sci USA 91 (1994) 3082-3086
8. Vanham G., Kestens L., De Meester I., et al. Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects. J Acq Immune Defic Syndr 6 (1993) 749-757
9. Lambeir A.M., Durinx C., Scharpe S., and De Meester I. Dipeptidyl-peptidase IV from bench to bedside: an update on strucutral properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 40 (2003) 209-214
10. Busso N., Wagtmann N., Herling C., et al. Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am J Pathol 166 (2005) 433-442
11. Gorrell M.D. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin Sci 108 (2005) 277-292
12. Fujita K., Hirano M., Ochiai J., et al. Serum glycylproline p-nitroanilidase activity in rheumatoid arthritis and systemic lupus erythematosus. Clin Chim Acta 88 (1978) 15-20
13. Constantinescu C.S., Kamoun M., Dotti M., et al. A longitudinal study of the T cell activation marker CD26 in chronic progressive multiple sclerosis. J Neurol Sci 130 (1995) 178-182
14. Korom S., De Meester I., Stadlbauer T.H., et al. Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. Transplantation 63 (1997) 1495-1500
15. Korom S., De Meester I., Maas E., et al. CD26 expression and enzymatic activity in recipients of kidney allografts. Transplant Proc 34 (2002) 1753-1754
16. Linardi A.P.P., Ferro E.S., and Hyslop S. Peptidase activities in rats treated chronically with N(omega)-nitro-l-arginine methyl ester (L-NAME). Biochem Pharmacol 68 (2004) 205-214
17. Mizuta T., Kawagushi A., Nakahara K., and Kawashima Y. Simplified rat lung transplantation using a cuff technique. J Thorac Cardiovasc Surg 97 (1989) 578-581
18. Belyaev A., Zhang X., Augustyns K., et al. Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors. J Med Chem 42 (1999) 1041-1052
19. Scharpé S., De Meester I., Vanhoof G., et al. Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2-naphtylamine. Clin Chem 34 (1988) 2299-2301
20. Yousem S.A., Berry G., Cagle P.T., et al., Lung Rejection Study Group. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection. J Heart Lung Transplant 15 (1996) 1-15
21. Nagayasu T., Oka I., Sawada T., et al. Expression of proliferating cell nuclear antigen in bronchial epithelium after lung transplantation in the rat. J Heart Lung Transplant 17 (1998) 566-571
22. Thom M., Palmer A., Cattell V., and Cook T. Proliferating cell nuclear antigen (PCNA) as a diagnostic marker of acute cellular rejection in routinely processed biopsies of renal allografts. Nephrol Dial Transplant 9 (1994) 153-155
23. Dang N.H., Torimoto Y., Sugita K., et al. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody: analysis of surface expression and human T cell activation. J Immunol 145 (1990) 3963-3971
24. Pacheco R., Martinez-Navio J., Lejeune M., et al. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Proc Natl Acad Sci USA 102 (2005) 9583-9588
25. Morimoto C., Torimoto Y., Levinson G., et al. 1F7, a novel cell surface molecule, involved in helper function of CD4 cells. J Immunol 143 (1989) 3430-3439
26. Hafler D.A., Chofflon M., Benjamin D., Dang N.H., and Breitmeyer J. Mechanisms of immune memory-T cell activation and CD3 phosphorylation correlate with Ta1 (CDw26) expression. J Immunol 142 (1989) 2590-2596
27. Korom S., De Meester I., Schmidbauer G., et al. Specific inhibition of CD26/DPP IV enzymatic activity in allograft recipients: effects on humoral immunity. Transplant Proc 31 (1999) 778
28. Groneberg D.A., Quarcoo D., Frossard N., and Fischer A. Neurogenic mechanisms in bronchial inflammatory diseases. Allergy 59 (2004) 1139-1152
29. Said S.I., and Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science 169 (1970) 1217-1218
30. Said S.I., and Rosenberg R. Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissues. Science 192 (1976) 907-908
31. Said S.I., and Dickman K.G. Pathways of inflammation and cell death in the lung: modulation by vasoactive intestinal peptide. Regul Pept 93 (2000) 21-29
32. Berisha H., Raza S., Bratut M., et al. Inhibition of apoptosis as a strategy for lung protection: caspase inhibitors prevent excitotoxic lung injury. Am J Respir Crit Care Med 159 (1999) 499
33. Dickman K., Mathew S.M., Berisha H.I., Bratut M., and Said S.I. Vasoactive intestinal peptide (VIP) inhibits caspase-3 activation: a basis for anti-apoptotic activity. Am J Respir Crit Care Med 161 (2000) 97
34. Kalfin R., Maulik N., Engelman R.M., et al. Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium. J Pharmacol Exp Ther 268 (1994) 952-958
35. Delgado M., Martinez C., Pozo D., et al. VIP and PACAP protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6. J Immunol 162 (1999) 1200-1205
36. Pozo D., Delgado M., Martinez C., et al. Immunobiology of vasoactive intestinal peptide (VIP). Immunol Today 21 (2000) 7-11
37. Nagahiro I., Yano M., Boasquevisque C.H., Fujino S., Cooper J.D., and Patterson A. Vasoactive intestinal peptide ameliorates reperfusion injury in lung transplantation. J Heart Lung Transplant 16 (1998) 417-421
38. Demuth H.U., McIntosh C.H., and Pederson R.A. Type 2 diabetes-therapy with dipeptidyl peptidase IV inhibitors. Biochim Biophys Acta 1751 (2005) 33-44
39. Weber A.E. Dipeptidyl peptidase IV inhibitors for the treatment of diabetes. J Med Chem 47 (2004) 4135-4141
40. Ghersi G., Chen W., Lee E.W., and Zukowska Z. Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides 22 (2001) 453-458
41. Proost P., De Meester I., Scholz D., et al. Aminoterminal truncation of chemokines by CD26/dipeptidyl peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemothaxis and HIV infection. J Biol Chem 273 (1998) 7222-7227
42. Struyf S., Proost P., Schols D., et al. CD26/dipeptidyl peptidase IV down regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J Immunol 162 (1999) 4903-4909
43. 2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor. J Immunol 161 (1998) 2672-2675
44. Miller L.A., and Butcher E.C. Human airway epithelial monolayers promote selective transmigration of memory T cells: a transepithelial model of lymphocyte migration into the airways. Am J Respir Cell Mol Biol 19 (1998) 892-900
45. Stephan M., Skripuletz T., Fowlie J.G., et al. A role of CD26/didpeptidyl peptidase IV (DPIV) in LPS-induced acute lung inflammation: studies in Fisher 344 substrains. Second International Conference on Dipeptidyl Aminopeptidases. Basic Sci Clin Appl (2005) 62
46. Cheng H., Abdel-Ghany M., and Pauli B.U. A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis. J Biol Chem 278 (2003) 24600-24607
47. Cheng H., Abdel-Ghany M., Elble R.C., and Pauli B.U. Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin. J Biol Chem 273 (1998) 24207-24215
48. Cheng H., Abdel-Ghany M., Zhang S., and Pauli B.U. Is the Fisher 344/CRJ rat a protein knock-out model for dipeptidyl peptidase IV-mediated lung metastasis of breast cancer?. Clin Exp Metastasis 17 (1999) 609-615